Union Bancaire Privee UBP SA Makes New $3.85 Million Investment in Marsh & McLennan Companies, Inc. $MRSH

Union Bancaire Privee UBP SA purchased a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the first quarter, according to its most recent filing with the SEC. The firm purchased 22,216 shares of the financial services provider’s stock, valued at approximately $3,853,000.

Several other hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC raised its stake in shares of Marsh & McLennan Companies by 51.2% during the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after buying an additional 2,960 shares during the last quarter. Bison Wealth LLC grew its stake in Marsh & McLennan Companies by 39.6% in the 4th quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock valued at $651,000 after acquiring an additional 869 shares during the last quarter. Glenview Trust co increased its holdings in Marsh & McLennan Companies by 10.8% during the 2nd quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock valued at $852,000 after acquiring an additional 379 shares in the last quarter. Osterweis Capital Management Inc. raised its position in Marsh & McLennan Companies by 18,440.0% during the second quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock worth $203,000 after acquiring an additional 922 shares during the last quarter. Finally, Diversify Advisory Services LLC purchased a new stake in shares of Marsh & McLennan Companies in the second quarter valued at about $1,307,000. 87.99% of the stock is owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Price Performance

NYSE:MRSH opened at $168.83 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 1.28. The company has a market capitalization of $81.56 billion, a PE ratio of 21.10, a PEG ratio of 2.46 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 1-year low of $156.60 and a 1-year high of $219.71.

Marsh & McLennan Companies (NYSE:MRSH) last announced its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. The firm had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. As a group, research analysts expect that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.

Insider Activity

In other news, CEO John Q. Doyle sold 16,656 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the sale, the chief executive officer owned 116,811 shares in the company, valued at $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on MRSH. Mizuho dropped their price objective on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Bank of America dropped their price target on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a research report on Tuesday, April 14th. JPMorgan Chase & Co. cut their price target on Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a report on Thursday, April 9th. Finally, Keefe, Bruyette & Woods upped their price objective on Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research report on Friday, April 17th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $200.19.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.